Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Jun-23 4:15 PM View:  | Young Richard A Director | Omega Therapeutics, Inc. (OMGA) | 02-Jun-23 | Sale (Planned) | 5,000 | $8.00 | $40,000.00 | (< 1%) 744.12K to 739.12K | |
| 03-May-23 4:05 PM View: | Young Richard A Director | Omega Therapeutics, Inc. (OMGA) | 01-May-23 | Sale (Planned) | 5,000 | $8.00 | $40,000.00 | (< 1%) 749.12K to 744.12K | |
| 10-Apr-23 4:05 PM View: | Young Richard A Director | Omega Therapeutics, Inc. (OMGA) | 06-Apr-23 | Sale (Planned) | 5,000 | $8.00 | $40,000.00 | (< 1%) 754.12K to 749.12K | |
| 20-Mar-23 4:05 PM View: | Young Richard A Director | Omega Therapeutics, Inc. (OMGA) | 17-Mar-23 | Sale (Planned) | 10,000 | $8.00 | $80,000.00 | (1%) 764.12K to 754.12K | |
| 27-Feb-23 5:20 PM View: | Flagship Pioneering Inc. 10% Owner | Omega Therapeutics, Inc. (OMGA) | 27-Feb-23 | Private Purchase | 3,323,310 | $5.78 | $19,208,700.00 | 13% 25.9M to 29.23M | |
| 11-Jan-23 4:14 PM View: | Young Richard A Director | Omega Therapeutics, Inc. (OMGA) | 10-Jan-23 | Sale (Planned) | 20,000 | $8.00 | $160,000.00 | (3%) 784.12K to 764.12K | |
| 15-Sep-22 4:10 PM View: | Young Richard A Director | Omega Therapeutics, Inc. (OMGA) | 14-Sep-22 | Sale (Planned) | 10,000 | $8.00 | $80,000.00 | (1%) 794.12K to 784.12K | |
| 03-Feb-22 4:05 PM View: | Karande Mahesh President and CEO Director | Omega Therapeutics, Inc. (OMGA) | 01-Feb-22 | Option Exercise | 11,300 | $0.53 | $5,989.00 | 11% 106.41K to 117.71K | |
| 05-Aug-21 5:43 PM View: | Flagship Pioneering Inc. 10% Owner | Omega Therapeutics, Inc. (OMGA) | 03-Aug-21 | Conversion | 22,528,700 | -- | -- | 1025% 2.2M to 24.73M | |
| 05-Aug-21 5:41 PM View: | Flagship Pioneering Inc. 10% Owner | Omega Therapeutics, Inc. (OMGA) | 03-Aug-21 | Market Purchase | 1,176,470 | $17.00 | $20,000,000.00 | 5% 24.73M to 25.9M | |
| 03-Aug-21 5:15 PM View: | Berry David A Director | Omega Therapeutics, Inc. (OMGA) | 03-Aug-21 | Market Purchase | 53,082 | $17.00 | $902,394.00 | 100% 0 to 53.08K | (3%) |
| 03-Aug-21 5:16 PM View: | Invus Public Equities, Lp 10% Owner | Omega Therapeutics, Inc. (OMGA) | 03-Aug-21 | Market Purchase | 875,000 | $17.00 | $14,875,000.00 | 63% 1.4M to 2.27M | |
| 05-Aug-21 5:41 PM View: | Flagship Pioneering Inc. 10% Owner | Omega Therapeutics, Inc. (OMGA) | 03-Aug-21 | Conversion Duplicate | 22,528,700 | -- | -- | 1025% 2.2M to 24.73M | |
| 03-Aug-21 5:16 PM View: | Invus Public Equities, Lp 10% Owner | Omega Therapeutics, Inc. (OMGA) | 03-Aug-21 | Conversion | 1,323,530 | -- | -- | 1765% 75.0K to 1.4M | |
| 03-Aug-21 5:16 PM View: | Sawhney Roger Chief Financial Officer | Omega Therapeutics, Inc. (OMGA) | 03-Aug-21 | Market Purchase | 2,941 | $17.00 | $49,997.00 | 100% 0 to 2.94K | (1%) |
| 05-Aug-21 5:43 PM View: | Flagship Pioneering Inc. 10% Owner | Omega Therapeutics, Inc. (OMGA) | 03-Aug-21 | Market Purchase Duplicate | 1,176,470 | $17.00 | $20,000,000.00 | 5% 24.73M to 25.9M | |
| 03-Aug-21 5:16 PM View: | Invus Public Equities, Lp 10% Owner | Omega Therapeutics, Inc. (OMGA) | 30-Jul-21 | Purchase | 75,000 | $16.14 | $1,210,340.00 | 100% 0 to 75.0K |
